DE69531459D1 - Elatase-inhibitoren - Google Patents

Elatase-inhibitoren

Info

Publication number
DE69531459D1
DE69531459D1 DE69531459T DE69531459T DE69531459D1 DE 69531459 D1 DE69531459 D1 DE 69531459D1 DE 69531459 T DE69531459 T DE 69531459T DE 69531459 T DE69531459 T DE 69531459T DE 69531459 D1 DE69531459 D1 DE 69531459D1
Authority
DE
Germany
Prior art keywords
inhibitors
elatase
elastase
compounds
human neutrophil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69531459T
Other languages
English (en)
Other versions
DE69531459T2 (de
Inventor
A Metz
L Gallion
P Burkhart
R Angelastro
P Peet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE69531459D1 publication Critical patent/DE69531459D1/de
Application granted granted Critical
Publication of DE69531459T2 publication Critical patent/DE69531459T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69531459T 1994-06-02 1995-05-05 Elatase-inhibitoren Expired - Lifetime DE69531459T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25279994A 1994-06-02 1994-06-02
US252799 1994-06-02
PCT/US1995/005618 WO1995033763A1 (en) 1994-06-02 1995-05-05 Novel elastase inhibitors

Publications (2)

Publication Number Publication Date
DE69531459D1 true DE69531459D1 (de) 2003-09-11
DE69531459T2 DE69531459T2 (de) 2004-06-24

Family

ID=22957608

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69531459T Expired - Lifetime DE69531459T2 (de) 1994-06-02 1995-05-05 Elatase-inhibitoren

Country Status (20)

Country Link
EP (1) EP0804465B1 (de)
JP (1) JP3623799B2 (de)
KR (1) KR100347285B1 (de)
CN (1) CN1149877A (de)
AT (1) ATE246708T1 (de)
AU (1) AU689589B2 (de)
CA (1) CA2189527C (de)
DE (1) DE69531459T2 (de)
DK (1) DK0804465T3 (de)
ES (1) ES2199992T3 (de)
FI (1) FI964781A (de)
HU (1) HU221197B1 (de)
IL (1) IL113940A (de)
NO (1) NO965097L (de)
NZ (1) NZ285565A (de)
PT (1) PT804465E (de)
SI (1) SI0804465T1 (de)
TW (1) TW403762B (de)
WO (1) WO1995033763A1 (de)
ZA (1) ZA954430B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3721538B2 (ja) * 1994-06-02 2005-11-30 メレル ファーマスーティカルズ インコーポレイテッド エラスターゼのパーフルオロアルキルケトン阻害剤およびそれらを製造する方法
HU221310B1 (en) * 1994-06-02 2002-09-28 Merrell Pharma Inc Acylated enol di and tripeptide derivatives, their use and pharmaceutical compositions comprising thereof
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
CN1791599A (zh) 2003-05-21 2006-06-21 贝林格尔.英格海姆国际有限公司 丙型肝炎抑制剂化合物
CA2573346C (en) 2004-07-20 2011-09-20 Boehringer Ingelheim International Gmbh Hepatitis c inhibitor peptide analogs
UY29016A1 (es) 2004-07-20 2006-02-24 Boehringer Ingelheim Int Analogos de dipeptidos inhibidores de la hepatitis c
JP2009538327A (ja) 2006-05-23 2009-11-05 アイアールエム・リミテッド・ライアビリティ・カンパニー チャネル活性化プロテアーゼ阻害剤である化合物および組成物
MX2009008518A (es) * 2007-02-09 2009-08-20 Irm Llc Compuestos y composiciones como inhibidores de la proteasa activadora de canal.
JP2023500182A (ja) 2019-09-17 2023-01-05 メレオ バイオファーマ ４ リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
DK4106757T3 (da) 2020-04-16 2023-10-23 Mereo Biopharma 4 Ltd Fremgangsmåder der involverer neutrofil elastase-inhibitor alvelestat til behandling af luftvejssygdom medieret af alpha-1-antitrypsin-mangel
CA3234399A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
DE3683541D1 (de) * 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
WO1992012140A1 (en) * 1990-12-28 1992-07-23 Georgia Tech Research Corporation Peptides ketoamides, ketoacids, and ketoesters
AU655831B2 (en) * 1991-08-22 1995-01-12 Merrell Pharmaceuticals Inc. Novel orally-active elastase inhibitors

Also Published As

Publication number Publication date
ES2199992T3 (es) 2004-03-01
JP3623799B2 (ja) 2005-02-23
HU9603312D0 (en) 1997-01-28
CA2189527C (en) 2000-12-19
FI964781A0 (fi) 1996-11-29
DK0804465T3 (da) 2003-11-24
CN1149877A (zh) 1997-05-14
CA2189527A1 (en) 1995-12-14
IL113940A0 (en) 1995-08-31
HU221197B1 (en) 2002-08-28
NO965097D0 (no) 1996-11-29
ATE246708T1 (de) 2003-08-15
AU2470995A (en) 1996-01-04
PT804465E (pt) 2003-12-31
KR100347285B1 (ko) 2003-01-15
MX9606030A (es) 1998-05-31
SI0804465T1 (en) 2003-12-31
AU689589B2 (en) 1998-04-02
FI964781A (fi) 1997-01-29
HUT76926A (hu) 1998-01-28
NZ285565A (en) 1998-08-26
ZA954430B (en) 1996-02-13
IL113940A (en) 1999-12-31
DE69531459T2 (de) 2004-06-24
NO965097L (no) 1997-01-31
TW403762B (en) 2000-09-01
WO1995033763A1 (en) 1995-12-14
EP0804465B1 (de) 2003-08-06
JPH10500992A (ja) 1998-01-27
EP0804465A1 (de) 1997-11-05

Similar Documents

Publication Publication Date Title
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ES2135062T3 (es) Pirazolo y pirrolopiridinas.
DK0793674T3 (da) Inhibitorer af human neutrofil elastase
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
PT1028954E (pt) Imidazoles substituidos uteis no tratamento de doencas inflamatorias
TR200000059T2 (tr) Piridin türevleri
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
DE69905368T2 (de) Oxydiertes thymosin beta 4
DE69920757D1 (de) Immunsuppressive wirkungen von pteridinderivaten
ATE246708T1 (de) Elatase-inhibitoren
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
ATE265455T1 (de) Tetrahydropyridoverbindungen
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
TR200001026T2 (tr) Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri.
BRPI0415355A (pt) triarilimidazóis
FI930265A (fi) Antikoagulantpeptider
NO20005548D0 (no) Mykobakterieinhibitorer
DE69726743D1 (de) Peptid analoge, die einen siebengliedrigen lactamring enthalten
EA199800822A1 (ru) Способ лечения избыточной агрессии
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.
MX9606031A (es) Inhibidores de cetona perfluoroalquilica de elastasa y procesos para fabricarlos.
PE61999A1 (es) Compuestos de tetrahidropiridina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS HOLDINGS INC., GREENVILLE, DEL., US

8327 Change in the person/name/address of the patent owner

Owner name: AVENTISUB II INC., GREENVILLE, DEL., US